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ABSTRACT
One challenge in biology is signal transduction monitoring in a physiological 
context. Intravital imaging techniques are revolutionizing our understanding of tumor 
and host cell behaviors in the tumor environment. However, these deep tissue imaging 
techniques have not yet been adopted to investigate the second messenger calcium 
(Ca2+). In the present study, we established conditions that allow the in vivo detection 
of Ca2+ signaling in three-dimensional tumor masses in mouse models. By combining 
intravital imaging and a skinfold chamber technique, we determined the ability of 
photodynamic cancer therapy to induce an increase in intracellular Ca2+ concentrations 
and, consequently, an increase in cell death in a p53-dependent pathway.
INTRODUCTION
The development of malignant tumors results from 
the deregulated proliferation of cells or from the inability 
of cells to undergo apoptotic death [1]. Consequently, 
apoptosis induction in tumor cells is one of the aims of 
anti-cancer therapy. Studies during the past decade have 
highlighted the importance of calcium (Ca2+) signaling in 
the regulation of key aspects of cell death. In particular, the 
modulation of Ca2+ signaling can change cell sensitivity to 
apoptotic signals, such as chemotherapeutic agents [2].
Several studies have indicated that the Ca2+ 
content of the endoplasmic reticulum (ER) determines 
cell sensitivity to apoptotic stress and that perturbation 
of ER Ca2+ homeostasis appears to be a key component 
in the development of several pathologies. Therefore, 
changes in the Ca2+ flux are regulated by Ca2+ release 
from the ER store toward the cytosol, and mitochondria 
can promote the survival of cancer cells, reducing 
sensitivity to apoptotic signals [3]. Although the majority 
of the mechanisms related to intracellular Ca2+ transport 
have been successfully elucidated either in vitro or in 
cultured cells, we still know little regarding the actual 
physiological role of these processes in the context of the 
tumor environment primarily due to technical limitations. 
However, recent advancements in imaging have allowed 
researchers to visualize transient changes in Ca2+ levels in 
live mice [4]. 
We recently demonstrated that tumor suppressors 
could modulate cell sensitivity to apoptosis by regulating 
Ca2+ transfer from the endoplasmic reticulum (ER) to 
mitochondria [5-7]. However, this intriguing signaling 
pathway has never been investigated in the tumor 
environment.
This study is the first to demonstrate the direct 
measurements of intracellular Ca2+ dynamics in vivo 
within tumor masses. Importantly, the methodology 
used in the present study is readily applicable to all the 
currently available fluorescent probes for following any 
intracellular parameter of interest. Finally, in the present 
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study, we demonstrate Ca2+-dependent p53-mediated 
apoptosis induced by phototherapy in cancer cells.
This approach will generate new opportunities for 
elucidating chemoresistance signaling in tumors and for 
developing new anti-cancer therapy.
RESULTS 
We adopted the well-known tumor suppressor 
p53 to generate a tumor model related to the loss of an 
onco-suppressor [8, 9]. The mechanism of action of p53 
is dependent on its transcription factor activity. Recently, 
a cytoplasmic fraction of p53 was suggested to directly 
modulate apoptosis via its cytoplasmic localization [10], 
which is a common requirement for tumor suppressors that 
can regulate ER-to-mitochondria Ca2+ transfer [6, 7, 11-
13].
We generated the following two stable clones to 
verify the relevance of the modulation of Ca2+ homeostasis 
by p53 in the tumor environment: the mouse embryo 
fibroblast (MEF) p53-/- clone that was transduced with 
H-RASV12 (p53-/- clone) and the MEF p53-/- clone that was 
transduced with H-RASV12 with re-introduced wild type 
(wt) p53 (p53+/+ clone) (Fig. 1A). We tested the anchorage-
independent growth, Ca2+ response and apoptotic 
sensitivity of these clones in vitro. As expected, the p53-
/- clone formed approximately twice as many colonies in 
soft agar (Fig. 1B). Moreover, the p53-/- clone displayed 
lower mitochondrial Ca2+ uptake after agonist stimulation, 
Figure 1: Defective Ca2+ homeostasis and apoptosis due to a lack of p53. (A) Generation of H-RASv12-transduced MEF 
clones. (B) Anchorage-independent growth of H-RASv12-transduced MEFs (p53+/+ clone and p53-/- clone). Pictures in the upper part are 
representative of colonies formed. For each well all colonies larger then 0.1 mm in diameter were counted using ImageJ software. (C) 
Mitochondrial Ca2+ response obtained with a mitochondria-targeted aequorin chimera after agonist stimulation with ATP (100 µM) (p53+/+ 
clone: [Ca2+]m peak 6.23 ± 0.44; p53
-/- clone: [Ca2+]m peak 2.99 ± 0.21) (p < 0.01). (D) Representative traces of mitochondrial Ca
2+ transient. 
(E) Apoptotic sensitivity of H-RASv12-transduced MEF clones (500 µM H2O2 for 6 hours). (F) Cytosolic Ca
2+ response of H-RASv12-
transduced MEF clones loaded with Fura-2 dye upon phthalocyanine (15 µM) photo-activation with visible (red) light from a 650 nm 
light emitting diode (LED). Microscopic fields of analyzed cells. (G) The ratio of Fura-2 fluorescence 340 nm/380 nm averaged with the 
color-matched regions of interest (ROIs) shown in (F), accompanied by statistical analysis. (H) Cell death analysis using the percentage of 
pyknotic nuclei in H-RASv12-transduced MEF clones upon phthalocyanine (15 µM) photo-activation. 
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as analyzed by aequorin technology [14], compared to that 
of the p53+/+ clone (Fig. 1C and D). This result indicates 
that p53 modulates intracellular Ca2+ homeostasis, 
presumably by blocking the Ca2+ responses generated from 
the ER, which is a condition that is known to be sufficient 
to reduce apoptotic sensitivity [15]. Thus, we tested 
the sensitivity of these two clones to a Ca2+-dependent 
apoptotic stimulus, H2O2. As consequence of less Ca
2+ 
mobilization, the p53-/- clone exhibited protection from 
apoptosis when compared to the MEFs clone expressing 
wt p53 (Fig. 1E). These results suggested that the efficacy 
of the apoptotic Ca2+ signals is p53-dependent.
The next step was to identify a stimulus that could 
induce an apoptotic Ca2+ signal within tumor masses 
using a drug currently applied in clinical cancer therapy. 
We selected the anti-cancer photosensitizer aluminum 
phthalocyanine chloride (phthalocyanine) for this purpose. 
Phthalocyanine is a light-activatable agent used in cancer 
photodynamic therapy (PDT) [16]. PDT combines a drug 
called a photosensitizer or photosensitizing agent with 
a specific type of light to kill cancer cells preferentially 
because these cells are more prone to accumulate this drug. 
Indeed, when the photosensitizer drug in tumors absorbs 
the light, an active form of oxygen is produced that 
destroys nearby cancer cells [17]. Several photosensitizers 
have been shown to localize to intracellular organelles, 
including the ER, where these photosensitizers promote 
reactive oxygen species (ROS)-mediated cell death upon 
illumination with suitable wavelengths of visible (red) 
light [18]. 
Because different pro-oxidant agents (i.e., H2O2 and 
menadione) can produce Ca2+-dependent cell death [5], we 
hypothesized that phthalocyanine should also produce a 
Ca2+ signal that results in a toxic effect. Thus, we analyzed 
the sensitivity of these clones to phthalocyanine in vitro. 
Phthalocyanine photo-activation with a LED 
light resulted in a rapid increase in the cytosolic Ca2+ 
concentration ([Ca2+]c) that slowly returned to basal 
levels, as measured using the ratiometric Ca2+ indicator 
Fura-2. Interestingly, the p53-/- clone had an impaired Ca2+ 
response (Fig. 1F and G, Videos S1 and S2) and were 
more resistant in terms of cell death upon phthalocyanine 
treatment compared to the p53+/+ clone, as indicated by the 
number of pyknotic nuclei appearing after LED irradiation 
(Fig. 1H). 
Next, we tested the involvement of p53 in the 
Figure 2: Intravital Ca2+ imaging in tumor masses. (A) Schematic representation of the skinfold chamber technique used to allow 
tumor formation and subsequent analysis by ratiometric confocal spinning disk intravital microscopy. (B) Representative images of tumor 
masses originated by the indicated H-RASv12-transduced MEF clones (p53+/+ and p53-/- clones) injected in athymic mice. (C) Cytosolic Ca2+ 
response measured within the tumors obtained by H-RASv12-transduced MEF clones injected into skinfold chambers mounted on athymic 
mice. Microscopic fields of analyzed cells. (D) The ratio of Fura-2 fluorescence 340 nm/380 nm accompanied by statistical analysis. 
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generation of pro-apoptotic Ca2+ signals evoked by 
cancer PDT in vivo. We developed a new intravital 
fluorescent microscopy technique to investigate Ca2+ 
signaling in single cells in tumor masses in live mice 
during PDT. The MEFs of the two clones were injected 
either subcutaneously or into a skinfold chamber [19] 
placed on the dorsal skin of athymic mice [20] (Fig. 2A). 
Subcutaneous tumors were excised after 2 weeks, and 
as expected, the p53-/- clone developed tumors that were 
double in size compared with the tumors that developed 
from p53+/+ clone (Fig. 2B). Tumors in the dorsal 
skinfold chamber were loaded with phthalocyanine and 
the ratiometric Ca2+ indicator Fura-2. Ca2+ signaling was 
monitored in live mice using a spinning disk confocal 
microscope (Fig. 2C). Live ratiometric Ca2+ images within 
the tumor mass and representative traces of the cytosolic 
Ca2+ response after phthalocyanine photo-activation 
are shown in Fig. 2C and D and in Videos S3 and S4. 
Higher Ca2+ responses were evoked in the tumor mass that 
developed from the p53+/+ clone compared to those from 
the tumor mass that developed from the p53-/- clone (Fig. 
2C and D, Videos S3 and S4). 
These results strongly suggest that the absence of a 
functional p53 precludes the generation of an efficient Ca2+ 
response during chemotherapeutic PDT that subsequently 
prevents the induction of apoptosis to limit tumor growth. 
To demonstrate this hypothesis, we modulated the 
Ca2+ response in vitro and in vivo to confirm the relation 
between p53-dependent differences in Ca2+ handling 
and apoptotic behavior. Because we determined that the 
p53-/- MEF clones have a reduced response to PDT due 
to reduced Ca2+ signaling, we used two different genetic 
strategies to restore the Ca2+ response and apoptosis: 
i) overexpression of the mitochondrial Ca2+ uniporter 
Figure 3: Increased Ca2+ response in p53-/- MEF clones after MCU overexpression restores sensitivity to PDT. (A) 
Mitochondrial Ca2+ response after agonist (100 µM ATP) stimulation of p53-/- MEF clone in resting condition or after MCU overexpression 
(p53-/- clone: [Ca2+]m peak 2.20 ± 0.45; p53
-/- clone + MCU: [Ca2+]m peak 8.28 ± 1.45) (p < 0.01). (B) Representative traces of mitochondrial 
Ca2+ transient. (C) and (D) Single-cell FRET measurements of PDT-induced mitochondrial Ca2+ uptake that are expressed as the maximal 
variation in the emission ratio (p53-/- clone: ΔR max 0.0311 ± 0.0043; p53-/- clone + MCU: ΔR max 0.0512 ± 0.0054) (p < 0.05). (E) 
Immunoblotting for typical apoptotic markers in p53-/- clone upon phthalocyanine (15 µM) photo-activation (PHTALO).
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(MCU) [21] and ii) overexpression of sarco-ER Ca2+-
ATPase pumps (SERCA) [22]. The overexpression of the 
MCU construct in the p53-/- clone increased the ability 
of mitochondria to accumulate Ca2+. Indeed, the [Ca2+]m 
rise evoked by agonist stimulation and measured using 
aequorin technology was increased in the p53-/- clone 
overexpressing MCU compared to the p53-/- clone (Fig. 
3A and B). These increased values were comparable to 
those observed in the p53+/+ clone (Fig. 1C), which is 
consistent with previous publications [23, 24]. We then 
analyzed the effect of MCU overexpression after PDT. 
Interestingly, PDT induced a Ca2+ response also in the 
mitochondrial matrix. In fact, cells transfected with the 
Ca2+-sensitive FRET-based probe 2mtD3cpv [25] and 
treated with phthalocyanine displayed a progressive 
increase in the FRET ratio (proportional to the 
mitochondrial Ca2+ concentration) after photo-activation-
induced Ca2+ waves. Furthermore, the stimulated Ca2+ 
uptake by mitochondria was significantly increased 
after MCU introduction (Fig. 3C and D). This increased 
Figure 4: Increased Ca2+ response in p53-/- MEF clones after SERCA overexpression restores sensitivity to PDT. (A) 
Mitochondrial Ca2+ response after agonist (100 µM ATP) stimulation of p53-/- clone in resting condition or after SERCA overexpression 
(p53-/- clone: [Ca2+]m peak 2.51 ± 0.31; p53
-/- clone + SERCA: [Ca2+]m peak 5.40 ± 0.56) (p < 0.01). (B) Representative traces of mitochondrial 
Ca2+ transient. (C) and (D) Ratiometric single-cell measurements of PDT-induced Ca2+ waves by Fura-2 that are expressed as the maximal 
variation in the excitation ratio (p53-/- clone: ΔR max 0.85 ± 0.02; p53-/- clone + SERCA: ΔR max 1.05 ± 0.06) (p < 0.01). (E) Immunoblotting 
for typical apoptotic markers in p53-/- clone upon phthalocyanine (15 µM) photo-activation (PHTALO).
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Figure 5: Reduced Ca2+ response in p53+/+ MEF clones with a Ca2+ chelator blocks the sensitivity to PDT. (A) Mitochondrial 
Ca2+ response after agonist (100 µM ATP) stimulation of p53+/+ clone in resting condition or after BAPTA-AM loading (p53+/+ clone: [Ca2+]
m peak 6.33 ± 0.97; p53
+/+ clone + BAPTA: [Ca2+]m peak 2.59 ± 0.83) (p < 0.05). (B) Representative traces of mitochondrial Ca
2+ transient. 
(C) and (D) Ratiometric single-cell measurements of PDT-induced Ca2+ waves by Fura-2 that are expressed as the maximal variation in the 
excitation ratio (p53+/+ clone: ΔR max 1.35 ± 0.07; p53+/+ clone + BAPTA: ΔR max 0.63 ± 0.04) (p < 0.01). (E) and (F) Single-cell FRET 
measurements of PDT-induced mitochondrial Ca2+ uptake that are expressed as the maximal variation in the emission ratio (p53+/+ clone: 
ΔR max 0.0824 ± 0.0102; p53+/+ clone + BAPTA: ΔR max 0.0048 ± 0.0045) (p < 0.01). (G) Immunoblotting for typical apoptotic markers 
in p53+/+ clone upon phthalocyanine (15 µM) photo-activation (PHTALO).
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mitochondrial Ca2+ responsiveness was associated with 
a re-established apoptotic sensitivity induced by PDT 
in vitro (Fig. 3E). As additional approach we used the 
overexpression of SERCA. Indeed its increased activity, 
and the subsequent ER Ca2+ overload have been previously 
demonstrated to promote apoptosis [5, 26]. In our studies, 
the overexpression of SERCA pumps in the p53-/- clone 
restored the mitochondrial Ca2+ response after agonist 
stimulation (Fig. 4A and B) as in the p53+/+ clone (Fig. 1C). 
Similar to the results obtained after MCU overexpression, 
also PDT-evoked Ca2+ release from the ER into the cytosol 
was increased (Fig. 4C and D), as measured using the 
ratiometric Ca2+ indicator Fura-2. Consequently, apoptotic 
sensitivity was rescued in the cells overexpressing SERCA 
pumps (Fig. 4E). These results support the evidence that 
the alteration of Ca2+ homeostasis observed in the absence 
of p53, is determinant for sensitivity to apoptosis and that 
modulating mitochondrial Ca2+ handling is possible to re-
sensitize cells to death.
Moreover, we used an approach for preventing 
Ca2+ signaling [27] in the p53+/+ clone to mimic the Ca2+ 
signaling conditions observed both in vitro and in vivo 
in the p53-/- clone to test the dependency of PDT-induced 
apoptosis on mitochondrial Ca2+ uptake. Using BAPTA-
Figure 6: Ca2+ signal in tumor masses is required for the anticancer effect of PDT. (A) Cytosolic Ca2+ response measured 
within the tumors in the skinfold chambers as the ratio of Fura-2 fluorescence 340 nm/380 nm induced upon phthalocyanine (15 µM) photo-
activation. (B) Levels of apoptosis measured as caspase activity (SR-FLIVO) within the tumor masses in the skinfold chambers. (C) In vivo 
imaging of apoptosis as the intensity of fluorescence (SR-FLIVO) emitted by a subcutaneous tumor mass upon phthalocyanine (15 µM) 
photo-activation. (D) Analysis of apoptosis in tumor tissue sections prepared upon in vivo phthalocyanine (15 µM) photo-activation and 
tumor excision. (E) Immunoblotting of homogenized tumors excised upon in vivo phthalocyanine (15 µM) photo-activation.
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AM, which is a well-known membrane permeable Ca2+ 
chelator, we were able to reduce the [Ca2+]m response 
evoked by agonist stimulation (Fig. 5A and B) to values 
similar to those observed in the p53-/- clone (Fig. 1C). 
We further assessed the effect of the chelator after PDT 
treatment on either the cytosolic (Fig. 5C and D) or 
mitochondrial Ca2+ response (Fig. 5E and F). The reduced 
ability of mitochondria to accumulate Ca2+ was associated 
with reduced sensitivity to PDT-induced apoptosis (Fig. 
5G) as observed previously in the p53-/- clone (Fig. 1H), 
probably due to a defective opening of the mitochondrial 
permeability transition pore [27, 28].
Then, we also validated our findings in vivo. First, 
we directly verified in the tumor masses (derived from the 
p53+/+ clone) grown in skinfold chambers and found that 
the activation of phthalocyanine was unable to induce a 
significant increase in Ca2+ concentration in the presence of 
BAPTA (Fig. 6A). Then, we directly linked Ca2+ response 
with apoptotic behavior using SR-FLIVO, which is a 
fluorescent probe used to detect apoptosis in vivo. Indeed, 
as shown in the lower panel of Fig. 6B, tumors treated 
with PDT exhibited reduced levels of caspase activity in 
the presence of BAPTA compared to levels of apoptosis in 
tumors not exposed to this Ca2+ chelator (Fig. 6B, upper 
panel). To further investigate the correlation between Ca2+ 
and apoptosis in vivo, two groups of mice were injected 
subcutaneously with the p53+/+ clones to induce tumor 
formation. After 14 days, the animals were pre-treated 
with a control (vehicle) or with BAPTA-AM for 1 hour 
at the level of the tumor nodules, irradiated with PDT and 
then injected with SR-FLIVO to image caspase-positive 
tumor cells. Fig. 6C clearly shows that the inhibition 
of Ca2+ signals reduced apoptotic activation in vivo (as 
previously observed in vitro). Finally, tumor nodules 
were excised and imaged by confocal microscopy (Fig. 
6D) or homogenized for Western blot analysis (Fig. 6E). 
Tumor cells treated with BAPTA displayed significantly 
decreased fluorescence (and thus, reduced apoptosis due 
to the inhibition of caspase activation) compared to that of 
the tumors not treated with BAPTA (p53+/+ clone). These 
results were confirmed by immunoblotting the extracted 
tumors with anti-caspase 3 antibody (Fig. 6E). 
Taken together, these results indicated that the de-
regulation of Ca2+ signaling in the absence of p53 reduces 
the sensitivity of tumor cells to PDT-induced apoptosis.
DISCUSSION 
Our ability to elucidate the details of intracellular 
signaling has improved remarkably in recent years. 
Technological innovations resulting from the development 
of new specialized optical microscopes and from the 
introduction of fluorescent indicators and proteins allow us 
to visualize events within a cell in real time and space [14]. 
These tools provide high sensitivity and great versatility 
while minimally perturbing the cell under investigation. 
Much of the recent progress in understanding the 
biology of cancer cells has been achieved via the study 
of key components of signaling and regulatory pathways. 
A widely studied signal transduction pathway in cancer 
cells is intracellular Ca2+ homeostasis [15]. Ca2+ plays 
roles in both tumor progression and the efficacy of 
chemotherapeutic agents [1], and the participation of 
this cation in the apoptotic process has been extensively 
demonstrated [16]. The link of Ca2+ to cancer and 
apoptosis was initially accepted with the discovery that 
the classical antiapoptotic protein Bcl-2 affected Ca2+ 
signaling. In particular, the antiapoptotic members 
of the Bcl-2 family cause a reduction in the ER Ca2+ 
concentration, while the opposite is true for proapoptotic 
proteins. Indeed, apoptotic sensitivity correlates with the 
total ER Ca2+ load and depends on the ability of cells to 
transfer Ca2+ from the ER to the cytosol [17]. Strikingly, 
proteins other than the proapoptotic members of the Bcl-
2 family act by modulating Ca2+ homeostasis. Indeed, in 
recent years, many other onco-suppressor proteins have 
been shown to reduce the Ca2+ release in the ER (albeit 
through completely different molecular mechanisms) 
and, consequently, to block the apoptotic responses 
[5,6,18–20]. However, all of these mechanisms have 
been successfully elucidated in vitro. In contrast, no data 
regarding the role of intracellular Ca2+ homeostasis are 
available in the context of the tumor environment in vivo 
in mice. 
In the present study, we combined the dorsal skinfold 
chamber technique with intravital microscopy to elucidate 
the involvement of p53 in the control of intracellular Ca2+ 
signals and apoptosis in three-dimensional tumor masses 
in living mice. The obtained data strongly indicate that 
p53-dependent dysregulated Ca2+ homeostasis causes 
reduced ER Ca2+ release that is associated with reduced 
responsivity to apoptotic stimulation. More interestingly, 
we showed that Ca2+ signals with amplitudes that are 
directly dependent on the presence of p53 and that are 
tightly linked with the generation of apoptosis in cancer 
cells are generated when the anti-cancer photosensitizer 
phthalocyanine, which is used in the photodynamic 
therapy of cancer, is activated. 
To our knowledge, this study is the first to report 
the direct measurements of intracellular Ca2+ dynamics in 
vivo within tumor masses under physiological conditions. 
Moreover, this imaging approach can be applied 
successfully to all the various GFP moieties and chimeras, 
as well as to all of the fluorescent probes that are available, 
to follow intracellular parameters of interest.
Overall, these results provide new insights into p53 
pathways underlying cancer and a method to monitor the 
kinetics of intracellular signals in tumor masses in vivo to 
verify the efficacy of anticancer treatments. 
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MATERIALS AND METHODS 
Reagents and solutions
ATP, histamine, digitonin, H2O2, and phthalocyanine 
were purchased from Sigma-Aldrich. Coelenterazine was 
purchased from Synchem. Fura-2 AM and BAPTA-AM 
were purchased from Invitrogen. 
Krebs-Ringer bicarbonate solution (KRB) 
contained 125 mM NaCl, 5 mM KCl, 1 mM MgSO4, 1 
mM Na2HPO4, 5.5 mM glucose, 20 mM NaHCO3, 2 
mM l-glutamine and 20 mM HEPES (pH 7.4) and was 
supplemented with 1 mM CaCl2.
Cell culture, transfection and cell death induction 
HeLa cells were obtained from the American 
Type Culture Collection. The HeLa cells were cultured 
in Dulbecco’s modified Eagle’s medium (DMEM) 
supplemented with 10% FCS and transfected using a 
standard calcium phosphate procedure. 
The MEFs were generated by crossing p53+/- mice 
and collecting cells from 13.5 d.p.c. embryos. The MEFs 
were cultured in DMEM supplemented with 10% FCS 
and treated with 500 µM H2O2 for 6 hours or with 15 µM 
phthalocyanine for 2 hours in complete medium. 
Detection of cell death
In vitro. Apoptosis was determined by different 
methods as indicated in the text: (i) by blotting for cell 
death markers, such as cleaved PARP or cleaved Caspase 
3, or (ii) by the automated detection of pyknotic nuclei. 
Briefly, cells were fixed and stained with DAPI, and 
images were acquired using an automated microscope 
as previously described. Then, pyknotic nuclei were 
identified by combining DAPI intensity and the nucleus 
form factor. 
In vivo. After an i.v. injection of 100 μl of SR-
FLIVO™ (Immunochemistry Technologies) via the lateral 
tail vein, the FLIVO reagent was allowed to circulate in 
the mouse for 30 minutes before analysis. Fluorescent 
in vivo images were acquired using an Odessey® CLx 
Imaging System (Li-Cor). Then, the tumors were excised, 
frozen, sectioned and stained for nuclei using DRAQ5 
according to the manufacturer’s protocol (Cell Signaling). 
After staining, the samples were mounted on coverslips 
and analyzed using a Zeiss LSM 510 confocal microscope 
equipped with a Fluor 40x/1.30 oil immersion objective. 
The acquired images were background corrected, and 
signals were analyzed using the open source Fiji software 
(available at http://fiji.sc/Fiji). 
Aequorin measurements
Cells grown on 13 mm round glass coverslips at 
50% confluence were transfected with the appropriate 
chimera cytAEQ or mtAEQ as previously described [7] 
alone or together with p53 wt expression constructs. 
All aequorin measurements were performed in KRB. 
Agonists were added to the same medium as specified in 
the figure legends. The experiments were terminated by 
lysing the cells with 100 µM digitonin in a hypotonic Ca2+-
rich solution (10 mM CaCl2 in H2O), thus discharging the 
remaining aequorin pool. The light signals were collected 
and calibrated to [Ca2+] values as previously described [7].
Fura-2 measurements
The cytosolic Ca2+ response was evaluated using the 
fluorescent Ca2+ indicator Fura-2/AM (Life Technologies, 
Invitrogen). The MEFs were grown on 24-mm coverslips 
and incubated at 37 °C for 30 minutes in 1 mM Ca2+/KRB 
supplemented with 2.5 mM Fura-2/AM, 0.02% Pluronic 
F-68 (Sigma-Aldrich), and 0.1 mM sulfinpyrazone 
(Sigma-Aldrich). Then, the cells were washed and 
supplied with 1 mM Ca2+/KRB. Next, the cells were placed 
in an open Leyden chamber on a 37 °C thermostated 
stage and exposed to 340/380 wavelength light using the 
Olympus xcellence (Olympus) multiple wavelength high-
resolution fluorescence microscopy system equipped with 
an Hamamatsu ORCA ER CCD camera (Hamamatsu 
Photonics) and a Upl FLN 40x oil objective (Olympus) 
to determine the cytosolic Ca2+ response. The photo-
activation of aluminum phthalocyanine chloride was 
obtained using an excitation filter ET576/25 (Semrock), 
with 500 milliseconds of excitation every FRET ratio 
cycle. The collected fluorescence data are expressed as 
emission ratios. 
FRET-based mitochondrial Ca2+ measurements 
MEF cells were grown on 24-mm coverslips 
transfected with 4mtD3cpv. After 36 hours, the cells were 
imaged using a Zeiss Axiovert 200M microscope with a 
cooled CCD camera (Photometrics), which was equipped 
with a C-apochromatic 40x/1.2 W CORR objective 
and controlled by MetaFluor 7.0 software (Universal 
Imaging). Emission ratio imaging of 4mtD3cpv was 
accomplished using a 436DF20 excitation filter, a 450 
nm dichroic mirror, and two emission filters (475/40 for 
ECFP and 535/25 for citrine) that were controlled by a 
Lambda 10-2 filter changer (Sutter Instruments, Novato, 
CA 94949, USA). The acquired fluorescence images were 
background corrected. The exposure times were typically 
100–200 milliseconds, and images were collected every 
second per wavelength. The photo-activation of aluminum 
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phthalocyanine chloride was achieved using an excitation 
filter ET650/50 (Chroma Technology Corp.), with 500 
milliseconds of excitation every FRET ratio cycle.
Transformation assays and in vivo tumorigenicity
Low-passage MEF clones infected with H-RASV12 
or H-RasV12 + p53 wt were resuspended in DMEM that 
was supplemented with 10% fetal bovine serum, penicillin 
(100 IU/ml) and streptomycin (100 IU/ml) and that 
contained 0.3% agarose. Then, the cells were plated on 
top of 1% agarose in the same medium at a cell density 
of 1 X 105 for each 60 mm plate. Colonies reaching at 
least 100 µm were scored after 14 days in culture. These 
experiments were performed in triplicate. 
To assess the tumorigenicity of H-RASV12-infected 
MEFs, 1 X 106 cells were injected subcutaneously on 
both sides of athymic mice, and tumors were excised after 
2 weeks. Procedures involving animals and their care 
conformed to institutional guidelines, and all experimental 
protocols were approved by the Animal Ethics Committee.
Dorsal skinfold chamber and intravital 
microscopy
Dorsal skin-fold chambers were transplanted onto 
7-week-old female athymic mice (Harlan), as described 
[8]. A cell pellet containing 106 tumor cells was placed 
onto the tissue surface (drop-on method) at three days post-
surgery. Intravital microscopy analyses were performed 
two weeks after cell inoculation as follows: the mice were 
anesthetized by halothane and transferred to a custom-
made warmed plate mounted on the stage of an upright 
spinning disk confocal system microscope (Olympus 
DSU) equipped with a water immersion objective (Fluor 
40x, 1.0 N.A., Nikon) for observation. The AM ester of 
Fura-2 (15 µM) and aluminum phthalocyanine chloride 
(dissolved in DMS at a final concentration of 15 µM) were 
loaded into each tumor mass by pressure injection with a 
glass microcapillary formed on a pipette puller (PP-830, 
Narishige). Cytosolic Ca2+ signals were tracked in the 
dorsal skinfold chamber by the sequential illumination 
of Fura-2 at 340 nm and 380 nm from two light emitting 
diodes. Fluorescence images were formed on the scientific 
complementary metal–oxide–semiconductor (sCMOS) 
sensor of a high-performance camera (pco.edge) under 
the control of software written in the laboratory. Images 
were acquired in vivo before, during and after the photo-
activation of aluminum phthalocyanine chloride with light 
from a 650 nm light emitting diode placed immediately 
above the microscope objective and directed onto 
the sample by reflection off a dichromatic short-pass 
mirror (Edmund Optics, part n. 69-217). The acquired 
images were processed off-line by software written in 
the laboratory using the Matlab environment (Release 
14, The MathWorks, Inc., Natick, MA, USA). Signals 
were measured as dye emission ratio changes using the 
following equation: ∆R = R(t) − R(0), where t is time, R(t) 
is the emission intensity excited at 340 nm divided by the 
intensity excited at 380 nm, and R(0) indicates the pre−
stimulus ratio. 
For the BAPTA-AM experiments, 1 μM BAPTA 
was loaded together with Fura-2 and phthalocyanine into 
each tumor mass. For the in vivo detection of apoptosis 
in the dorsal skinfold chamber, SR-FLIVO (see previous 
paragraph) was injected in situ and incubated for 60 
minutes in the exposed area, and excess fluorophore was 
extensively washed with PBS. Then, images were acquired 
using the previously described imaging system, which 
was equipped with a Zeiss EC Plan-Neo fluor 5x/0.16 
objective.
Statistical analysis of data
The statistical data are presented as the mean ± 
SE. Significance was calculated by Student’s t-test, and 
correlation analysis was conducted using SigmaPlot 5.0 
software (SPSS Inc.).
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